When it comes to medical research and advancement, we usually hear about the results of a successful study or a new drug in the latter stages of a clinical trial. Rarely does the media report on trials gone wrong or the unethical aspects of medical research. This is starting to change. A May 16 New York Times article, "Drug Trials Hide Conflicts for Doctors," presented a scathing view of the patient recruitment process, the result of a 10-month investigation. The report highlights the disturbing trend of pharmaceutical companies that offer doctors financial incentives to recruit patients in a timely fashion.
Clinical Trial Methods Attracting Closer Media Scrutiny of Patient Recruitment
You might also be interested in:
- How LEGO's Global Innovation STEM Award Program Cut Through the Media Clutter
- 8 Video Scripting Tips for PR Pros
- Get Emotional and Watch Fans Share Your Content More Frequently
- Periscope Up: How Southwest, Adobe and Human Rights Campaign Use PR’s Hottest New App
- How to Protect Your Brand From Digital Information Leaks